Search

for
Search:

Research

5 / 1000+ results

research Social media for arthritis-related comparative effectiveness and safety research and the impact of direct-to-consumer advertising

20 citations , March 2017 in “Arthritis research & therapy”

In this study, researchers analyzed social media data to assess the comparative safety of arthritis medications, finding increased odds of herpes zoster and perforated bowel with certain therapies. Social media posts expressed more safety concerns than favorable opinions about drug safety.

research Research Trends and Hotspots in Female Pattern Hair Loss: A Bibliometric Study

July 2025 in “Journal of Cosmetic Dermatology”

This study analyzed global research on female pattern hair loss from 1957 to 2024, reporting trends in publication output and hotspots in topics like treatment mechanisms and safety, with the USA leading in contributions and citations.

research A scientometric study on research trends and characteristics of discoid lupus erythematosus

October 2024 in “Journal of Dental Sciences”

This study analyzed research trends in discoid lupus erythematosus, revealing shifting focus areas and highlighted the importance of interdisciplinary collaboration between dermatology and other fields.

research Nanotechnology in Dermatology

60 citations , January 2014 in “Anais Brasileiros De Dermatologia”

This article discusses the foundational concepts of nanotechnology and its contributions to dermatology and medicine, but does not present new research findings.

research Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata

222 citations , September 2016 in “JCI insight”

This research overview highlights that although JAK inhibitors show promise as potential treatments for alopecia areata based on recent insights into the disease mechanism, their efficacy has not yet been thoroughly evaluated in a systematic manner.

View more "safety research" in research →

Community Join

5 / 912 results

community Research behind RU-58642? Has anyone heard of this?

in Research/Science 1 upvotes 1 year ago

RU-58642 is a powerful anti-androgen that was not developed further, possibly due to safety concerns or financial reasons. RU58841 is a topical alternative, but it is less effective than finasteride and dutasteride, and its long-term effects are not well-studied.

community [Research Breakdown] The Genetic Edge: Unpacking Dutasteride vs Finasteride Potency

6 upvotes 3 weeks ago

Dutasteride is more effective than finasteride for increasing hair count, but finasteride is considered safer for long-term use unless hair loss is very aggressive. Starting with finasteride is recommended due to its effectiveness and safety profile.

community Research: A Cheap Sugar for Hair Regrowth

15 upvotes 2 years ago

A natural sugar called 2dDR may stimulate hair growth and is comparable to minoxidil, but it's not widely available for purchase. Concerns about minoxidil's safety for pets were discussed, with some users seeking alternatives.

community Research: Minoxidil grows hair by suppressing androgen activity (DHT) in hair follicles.

43 upvotes 6 years ago

Minoxidil may suppress androgen activity in hair follicles, potentially aiding in hair growth and prostate cancer treatment. Users discuss the effectiveness of minoxidil and finasteride for hair maintenance and regrowth, with some preferring topical applications over oral due to safety concerns.

community How can I safely apply RU58841 whilst I have children in the house?

in Treatment 8 months ago

RU58841 is not recommended for use around children due to potential exposure risks. Alternatives like CB-03-01 might be considered, but further research is advised.

View more "safety research" in community →

Learn

10 / 801 results

learn sh-Polypeptide-7

Are there any safety concerns or allergic reactions associated with sh-Polypeptide-7 in topical hair products? There are no published human studies on sh-Polypeptide-7 itself, so its safety is unestablished; research on cosmetic peptides as a class reports low irritation and rare allergy, and dermatologists advise patch testing a new scalp product.

learn Setipiprant

What side effects or limitations have been reported with Setipiprant use in hair loss research? In the one published hair-loss trial (DuBois 2021, 169 men, 24 weeks), setipiprant produced no significant hair regrowth over placebo. Treatment-related side effects — mostly mild headaches, stomach upset and fatigue — were reported in about a quarter of the setipiprant group versus just over twelve percent on placebo, and no serious events were attributed to the drug. It is an unapproved, experimental compound with no long-term safety data.

learn KX-826

Kintor Pharmaceutical: KX-826, a New Name in Hair Loss Research KX-826 (pyrilutamide) is an experimental topical androgen receptor blocker from Kintor Pharmaceutical. It is not approved as a medicine anywhere; the company reports that its China Phase III trial met its primary endpoint at 24 weeks, but the trial data has been released through corporate announcements rather than peer-reviewed journals and long-term safety is unknown.

learn GT20029

research compound made to degrade androgen receptors in scalp

learn RU58841

Is RU58841 magic or a scam? Does it really stop baldness? RU58841 is an unapproved research chemical: the published evidence is animal and lab work from the 1990s, there has never been a controlled human trial for hair loss, and nothing sold online is quality-controlled — so its effect and its long-term safety in people are both unknown.

learn HMI-115

much-hyped research compound targeting prolactin receptor in scalp

learn PP405

mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials

learn Beta Polypeptide

learn Fluridil

a topical anti-androgen with less systemic involvement

learn Latanoprost

Can latanoprost be safely applied to the scalp, or is it only for eyelashes? Latanoprost is not approved for use on the scalp and its safety there has not been established: the only human scalp evidence is one 24-week pilot trial in 16 men, and clinicians flag irritation, skin darkening and unknown absorption over a large area as open risks.

View more "safety research" in learn →

Clinics

6 / 19 results

All 19 clinic results →

Experts

— no results

Try a deeper search in experts →